登革热眼部表现的系统综述与Meta分析
该系统综述与Meta分析检索PubMed、CINAHL和LILACS,纳入32项观察性研究共11426例登革热患者,采用随机效应模型合并眼部表现患病率。眼部表现合并患病率为0.32(95%CI:0.22-0.45,I²=91.8%),异质性显著,作者强调需提高临床认识并建议未来开展前瞻性标准化眼科评估。
要点
- 登革热患者眼部表现合并患病率为0.32(95%CI:0.22-0.45,I²=91.8%)。
- 视网膜出血合并患病率0.08(95%CI:0.05-0.12),黄斑病变0.04(95%CI:0.02-0.08)。
- 研究间异质性显著,可能源于诊断标准、研究人群和疾病严重程度差异。
核心结论
- 登革热患者眼部表现患病率较高,强调尤其在流行区需提高临床认识。
- 鉴于报告患病率存在异质性,作者认为未来研究应聚焦前瞻性、标准化的眼科评估以改善早期诊断和管理。
研究设计与样本
- 系统综述与Meta分析,检索PubMed、CINAHL和LILACS,纳入报告登革热患者眼部表现患病率的观察性研究。
- 共纳入32项研究、11426例患者,采用Hoy等工具评估偏倚风险,随机效应模型计算合并患病率,I²统计量评估异质性。
主要发现
- 眼部表现合并患病率(基于16项研究)为0.32(95%CI:0.22-0.45,I²=91.8%)。
- 球后疼痛合并患病率0.20(95%CI:0.10-0.37,I²=99.6%),视力模糊0.11(95%CI:0.05-0.23,I²=92.8%)。
- 结膜下出血合并患病率0.18(95%CI:0.10-0.30,I²=94.1%),视网膜出血0.08(95%CI:0.05-0.12,I²=77.8%)。
- 黄斑病变合并患病率0.04(95%CI:0.02-0.08,I²=91.6%),葡萄膜炎0.05(95%CI:0.01-0.24,I²=97.4%)。
- 研究间观察到显著异质性,可能原因包括诊断标准、研究人群和疾病严重程度差异。
关键数值与推荐
- 眼部表现合并患病率0.32(95%CI:0.22-0.45,I²=91.8%,基于16项研究)。
- 球后疼痛0.20(95%CI:0.10-0.37,I²=99.6%),视力模糊0.11(95%CI:0.05-0.23,I²=92.8%)。
- 结膜下出血0.18(95%CI:0.10-0.30,I²=94.1%),视网膜出血0.08(95%CI:0.05-0.12,I²=77.8%)。
- 黄斑病变0.04(95%CI:0.02-0.08,I²=91.6%),葡萄膜炎0.05(95%CI:0.01-0.24,I²=97.4%)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 研究间观察到显著异质性,可能源于诊断标准、研究人群和疾病严重程度差异。
- 作者认为未来研究应聚焦前瞻性、标准化的眼科评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
TOPIC: Ocular manifestations in dengue fever remain underrecognized despite reports of vision-threatening complications. This systematic review and meta-analysis aimed to determine the pooled prevalence of ocular manifestations in dengue patients, characterizing their spectrum, frequency, and clinical significance. CLINICAL RELEVANCE: Dengue fever affects millions globally, predominantly in tropical regions. While systemic complications are well documented, ophthalmic involvement remains poorly defined, with variable prevalence estimates and unclear risk factors. Early recognition is crucial for timely intervention, particularly in endemic areas where clinical suspicion is low. METHODS: A comprehensive search was conducted in PubMed, CINAHL, and LILACS. Eligible studies included observational studies reporting the prevalence of ocular manifestations in dengue patients. Risk of bias was assessed using Hoy et al.'s tool for prevalence studies. Pooled prevalence estimates were calculated using a random-effects model, and heterogeneity was assessed using I2 statistics. RESULTS: A total of 32 studies, including 11,426 patients, were included. The pooled prevalence of ocular manifestations, calculated from 16 studies, was 0.32 (95% CI: 0.22-0.45, I2 = 91.8%). Retro-ocular pain had a pooled prevalence of 0.20 (95% CI: 0.10-0.37, I2 = 99.6%), while blurred vision was reported in 0.11 (95% CI: 0.05-0.23, I2 = 92.8%). Among structural manifestations, subconjunctival hemorrhage had a prevalence of 0.18 (95% CI: 0.10-0.30, I2 = 94.1%), retinal hemorrhage 0.08 (95% CI: 0.05-0.12, I2 = 77.8%), maculopathy 0.04 (95% CI: 0.02-0.08, I2 = 91.6%), and uveitis 0.05 (95% CI: 0.01-0.24, I2 = 97.4%). Significant heterogeneity was observed across studies, likely due to differences in diagnostic criteria, study populations, and disease severity. CONCLUSION: This study highlights a substantial prevalence of ocular manifestations in dengue patients, emphasizing the need for increased clinical awareness, particularly in endemic regions. Given the heterogeneity in reported prevalence, future research should focus on prospective, standardized ophthalmologic assessments to improve early diagnosis and management.
引用
- Haslam AX, Blandón MDMT, Castro ASR, et al. Ocular manifestations in Dengue Fever: A Systematic Review and Meta-Analysis. Am J Ophthalmol. 2025. PMID: 40819701. doi:10.1016/j.ajo.2025.08.021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。